 |  |
 | |
Expert Roundtable on
Sublingual Immunotherapy
FACULTY:
Linda Cox, MD, FAAAAI • Thomas Casale, MD, FAAAAI • Peter Creticos, MD, FAAAAI • Stephen Durham, MA, MD, FRCP |
 |  |
 |  |
|
 |
| RELEASE DATE: September 15, 2014 • EXPIRATION DATE: September 15, 2016 |
Agenda
Sublingual Immunotherapy |
| Welcome and Introductions |
| Mechanisms of Actions of Sublingual Immunotherapy (SLIT) |
| Biomarkers to Predict Response to Therapy |
| U.S. Clinical Trials and SLIT in the Research Setting |
| Practice Aspects of SLIT: Adherence, Instructions, and Costs |
| Open Panel Discussion |
| Program Overview This educational activity presents an Expert Roundtable hosted by the Journal of Allergy and Clinical Immunology: In Practice (JACI: In Practice). The moderator, Linda Cox, MD, and a panel of leading authorities in the field of allergy and immunotherapy discuss the treatment of patients with allergic rhinitis with or without conjunctivitis with sublingual immunotherapy (SLIT). Reviewing current data, clinical trial results, and practical experience of treating patients, this video program provides valuable guidance in the optimal use of SLIT in patients with allergic rhinitis. Target Audience This educational activity has been developed for allergist/immunologists, primary care physicians, and nurse practitioners who treat patients with allergic rhinitis. Educational Objectives Upon completion of this activity, participants should be able to: |
| • | Recognize the mechanisms of action of sublingual immunotherapy (SLIT) and differentiate them from that of subcutaneous immunotherapy (SCIT). |
| • | Evaluate the currently available research about biomarkers and how they may be used to predict the effectiveness of immunotherapy. |
| • | Identify relevant data from U.S. clinical trials on the use of SLIT and how the results compare with SCIT. |
| • | Distinguish how factors such as safety, clinical monitoring, and cost affect patient adherence to the use of SLIT. |
| CME Accreditation The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. The AAAAI is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education credits for physicians. Fee Information There are no fees associated with this activity. Commercial Support Programmed by the AAAAI. Funded through an independent education grant from Merck & Co. | ||
|
 |
This message has been sent to ivancev@gmail.com from Elsevier Communications on behalf of Elsevier Health Advance.
If you no longer wish to receive messages of this nature from us in the future, please click here. Visit the Elsevier Preference Center to manage more of your communication preferences with us. Copyright © 2014 Elsevier B.V.. All rights reserved. | Elsevier Privacy Policy Elsevier B.V. Registered Office: Radarweg 29, 1043 NX Amsterdam, The Netherlands. Reg. No. 33158992 – Netherlands. VAT No. NL 005033019B01. |
No comments:
Post a Comment